EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

36 417 2025

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Editorial

Comparison of lansoprazole and omeprazole treatment in grade II and III reflux esophagitis

Sadık YILDIRIM ¹ , Levent ERDEM ² , Hakan M. KÖKSAL ³ , Adil BAYKAN ⁴

Author Affiliation(s)

1.

Şişli Etfal Hastanesi 1. Genel Cerrahi Klinikleri, İstanbul

2.

İstanbul Tıp Fakültesi Gastroenterohepatoloji Bilim Dalı İstanbul

3.

Departments of General Surgery, Şişli Etfal Training and Research Hospital, İstanbul

4.

Şişli Etfal Teaching and Research Hospital, Departments of General Surgery, Ankara

Turk J Gastroenterol 2001; 12: 117-121

Keywords : Esophagitis, lansoprazole, omeprazole

Read: 1488 Published: 25 July 2019

Volume 12, Issue 2, June 2001

Previous Article